Baseline factors | HDDT group (N = 24) | BQT group (N = 25) | P-value |
---|---|---|---|
Sex (female: male) | 15:9 | 14:11 | 0.644 |
Age (years) | 41.8 ± 12.3 | 47.5 ± 13.9 | 0.131 |
Body mass index (kg/m2) | 23.5 ± 2.5 | 24.2 ± 3.4 | 0.441 |
Marital status (single or divorced: married) | 3:21 | 4:21 | 1.000 |
Place of residence (suburban area: urban area) | 16:8 | 21:4 | 0.158 |
Drinking water (tap water: well water) | 364:6 | 365:5 | 0.761 |
Style of dining (dining at home: dining out) | 20:4 | 22:3 | 0.953 |
Education status (Junior high school and below: high school: college or more) | 9:8:7 | 10:10:5 | 0.745 |
Smoking (yes: no) | 21:3 | 19:6 | 0.503 |
Drinking (yes: no) | 23:1 | 21:4 | 0.370 |
Digestive Symptoms | 18(75.0%) | 15(60.0%) | 0.263 |
 Abdominal pain | 10(41.7%) | 6(24.0%) | 0.187 |
 Heartburn | 1(4.2%) | 2(8.0%) | 1.000 |
 Acid reflux | 7(29.2%) | 3(12.0%) | 0.256 |
 Abdominal distension | 5(20.8%) | 6(24.0%) | 0.791 |
 Belching | 3(12.5%) | 2(8.0%) | 0.962 |
Endoscopy diagnosis | Â | Â | Â |
 Superficial gastritis | 8(33.3%) | 8(32.0%) | 0.921 |
 Erosive/Hemorrhagic gastritis | 16(66.7%) | 14(56.0%) | 0.444 |
 Atrophic gastritis/Intestinal metaplasia | 3(12.5%) | 4(16.0%) | 1.000 |
 Gastric polyp | 1(4.2%) | 3(12.0%) | 0.632 |
Family history of gastric carcinoma | 2(8.3%) | 0(0.0%) | 0.452 |
 Chronic disease history | 3(12.5%) | 3(12.0%) | 1.000 |
 Hypertension | 1(4.2%) | 1(4.0%) | 1.000 |
 Diabetes mellitus | 2(8.3%) | 0(0.0%) | 0.452 |
 Hyperlipidemia | 1(4.2%) | 2(8.0%) | 1.000 |
Long-term medication history | 2(8.3%) | 1(4.0%) | 0.971 |
 Antihypertensive drugs | 1(4.2%) | 1(4.0%) | 1.000 |
 Hypoglycemic agents | 1(4.2%) | 0(0.0%) | 0.984 |
History of antibiotics use in two years | 13(54.2%) | 11(44.0%) | 0.670 |
 Penicillin | 12(50.0%) | 8(32.0%) | 0.200 |
 Cephalosporin | 9(37.5%) | 6(24.0%) | 0.305 |
 Ofloxacin | 3(12.5%) | 0(0.0%) | 0.632 |
 Metronidazole/ tinidazole | 1(4.2%) | 1(4.0%) | 1.000 |